Streetbeat News

Products Services

MSFT

Microsoft Gaming CEO Phil Spencer reassured Xbox employees in a recent meeting that the company will continue producing Xbox consoles, countering rumors of a shift away from console manufacturing. This statement comes amid concerns following recent layoffs and ahead of a business update event. Spencer's comments also address speculation about Xbox's future strategy and potential shifts towards multi-platform gaming.

Portfolio Pulse from Franca Quarneti

February 12, 2024 | 5:14 pm

GOLD

IVPAF

The U.S. is increasing its involvement in African mining and infrastructure to compete with China's dominance in strategic mineral supply chains, focusing on the Copperbelt region for cobalt and copper crucial for decarbonization. The U.S. supports the Lobito corridor rail project, which will reduce transportation costs for mining companies like Ivanhoe Mines Ltd, potentially joined by Anglo American, Barrick Gold Corp, and First Quantum Minerals Ltd. This move is part of a broader strategy to secure supplies of essential minerals for renewable energy.

Portfolio Pulse from Matt Whittaker

February 12, 2024 | 5:09 pm

AMZN

MSFT

NVDA

Microsoft's Azure is rapidly closing the gap with Amazon's AWS, growing from half to three-quarters the size of AWS in five years. Analysts predict Azure's revenue could reach $95 billion in two years, potentially shifting investor optimism towards Microsoft's cloud segments. Microsoft now boasts 53,000 Azure AI customers, leveraging its early lead in AI. In response, AWS has expanded its offerings, including partnerships with Anthropic and a focus on Nvidia chips for compute instances. Microsoft's cloud infrastructure now accounts for 29% of its revenue and 46% of its total operating income, with significant improvements in gross margin.

Portfolio Pulse from Anusuya Lahiri

February 12, 2024 | 5:08 pm

BAX

Barclays has reaffirmed its Overweight rating on Baxter Intl (NYSE:BAX) and increased its price target from $52.00 to $54.00. Baxter Intl's shares are currently trading at $39.55, and the new price target suggests a potential upside of 36.54%. Baxter, known for its medical instruments and supplies, acquired Hillrom in 2021, enhancing its hospital-focused offerings. The company plans to spin off its kidney failure treatment operations by mid-2024.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:00 pm

RXST

Stifel has reaffirmed its Buy rating on RxSight (NASDAQ:RXST) and increased its price target from $45.00 to $54.00. RxSight, a medical technology company focused on improving vision post-cataract surgery, is currently trading at $49.77. The new price target suggests an 8.5% potential upside. Analyst ratings are crucial for investors, offering insights into stock performance based on detailed research and analysis.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:00 pm

TTOO

T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose after announcing FDA 510(k) clearance for the expanded T2Bacteria Panel, which now includes detection of Acinetobacter baumannii. This addition enhances the panel's coverage to approximately 75% of sepsis-causing pathogens. The company is set to report Q4 financial results soon. The stock's movement is also discussed in the context of technical analysis, with its 200-day moving average noted.

Portfolio Pulse from Erica Kollmann

February 12, 2024 | 4:52 pm

TTOO

T2 Biosystems' stock is trading higher following the announcement that the FDA has granted 510(k) clearance for the expanded T2Bacteria panel, indicating regulatory approval for an enhanced version of their diagnostic tool.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 4:38 pm

AAPL

GOOG

IWM

NVDA

SPY

The article discusses the potential of small caps, represented by the iShares Russell 2000 ETF (IWM), highlighting their performance relative to the S&P 500 and factors that could influence their future performance. It also covers early trade money flows for several major companies and ETFs, including positive flows for NVIDIA (NVDA), neutral for Apple (AAPL), Amazon (AMZN), Meta Platforms (META), and Microsoft (MSFT), negative for Alphabet (GOOG) and Tesla (TSLA), and mixed for SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ Trust (QQQ). Additionally, it mentions the performance of Bitcoin, gold, and oil, with specific ETFs for gold (GLD) and oil (USO) mentioned.

Portfolio Pulse from The Arora Report

February 12, 2024 | 4:37 pm

NNOX

Nano-X Imaging's shares are experiencing an uptick following the FDA 510(k) approval received by its subsidiary, Nano-X AI, for the HealthFLD system, designed to detect early signs of fatty liver disease.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 4:32 pm

MELI

Investors have shown a bearish stance on MercadoLibre (NASDAQ:MELI) through unusual options trading activity, with a sentiment split of 26% bullish and 73% bearish. The trading targets a price range of $1240.0 to $2000.0 for MELI over the next three months. The company, which operates Latin America's largest e-commerce marketplace, has seen its stock price slightly increase by 0.04%, with an upcoming earnings announcement in 14 days.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 4:31 pm